Search research articles
Contact Us
Filters
Showing results (51-60 of 82) with videos related to
Page
of 9
Sort By:
Nature Cancer
|
April 10, 2023
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Arash Nabbi, Arnavaz Danesh, Osvaldo Espin-Garcia, et al.
The Lancet. Haematology
|
November 26, 2021
Polatuzumab vedotin plus obinutuzumab and lenalidomide in patients with relapsed or refractory follicular lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
Catherine Diefenbach, Brad S Kahl, Andrew McMillan, et al.
BMC Genomics
|
June 10, 2016
Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment
Mihai Pop, Joseph N Paulson, Subhra Chakraborty, et al.
Open Biology
|
August 15, 2019
The anti-parasitic agent suramin and several of its analogues are inhibitors of the DNA binding protein Mcm10
Carolyn N Paulson, Kristen John, Ryan M Baxley, et al.
Haematologica
|
October 15, 2020
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study
Christopher R Bolen, Magdalena Klanova, Marek Trneny, et al.
Nature Communications
|
March 7, 2024
bacLIFE: a user-friendly computational workflow for genome analysis and prediction of lifestyle-associated genes in bacteria
Guillermo Guerrero-Egido, Adrian Pintado, Kevin M Bretscher, et al.
JCO Precision Oncology
|
January 18, 2024
Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial
Ian E Krop, Lorenza Mittempergher, Joseph N Paulson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 19, 2025
Poor Surgical Outcomes Following <i>Paenibacillus</i> Infant Infectious Hydrocephalus
Jessica E Ericson, Davis Natukwatsa, Peter Ssenyonga, et al.
Microbiome
|
February 17, 2017
Mentholation affects the cigarette microbiota by selecting for bacteria resistant to harsh environmental conditions and selecting against potential bacterial pathogens
Jessica Chopyk, Suhana Chattopadhyay, Prachi Kulkarni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2019
Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Laurie H Sehn, Alex F Herrera, Christopher R Flowers, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 82) with videos related to
Sort By:
Page
of 9
Nature Cancer
|
April 10, 2023
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Arash Nabbi, Arnavaz Danesh, Osvaldo Espin-Garcia, et al.
The Lancet. Haematology
|
November 26, 2021
Polatuzumab vedotin plus obinutuzumab and lenalidomide in patients with relapsed or refractory follicular lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
Catherine Diefenbach, Brad S Kahl, Andrew McMillan, et al.
BMC Genomics
|
June 10, 2016
Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment
Mihai Pop, Joseph N Paulson, Subhra Chakraborty, et al.
Open Biology
|
August 15, 2019
The anti-parasitic agent suramin and several of its analogues are inhibitors of the DNA binding protein Mcm10
Carolyn N Paulson, Kristen John, Ryan M Baxley, et al.
Haematologica
|
October 15, 2020
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study
Christopher R Bolen, Magdalena Klanova, Marek Trneny, et al.
Nature Communications
|
March 7, 2024
bacLIFE: a user-friendly computational workflow for genome analysis and prediction of lifestyle-associated genes in bacteria
Guillermo Guerrero-Egido, Adrian Pintado, Kevin M Bretscher, et al.
JCO Precision Oncology
|
January 18, 2024
Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial
Ian E Krop, Lorenza Mittempergher, Joseph N Paulson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 19, 2025
Poor Surgical Outcomes Following <i>Paenibacillus</i> Infant Infectious Hydrocephalus
Jessica E Ericson, Davis Natukwatsa, Peter Ssenyonga, et al.
Microbiome
|
February 17, 2017
Mentholation affects the cigarette microbiota by selecting for bacteria resistant to harsh environmental conditions and selecting against potential bacterial pathogens
Jessica Chopyk, Suhana Chattopadhyay, Prachi Kulkarni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2019
Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Laurie H Sehn, Alex F Herrera, Christopher R Flowers, et al.
Page
of 9